00:00I would start by saying that science is a collective challenge, where collaboration is fundamental.
00:11The team play is fundamental, where we have to put experience, competence and human capital in common.
00:21In addition, I think that the actors present at today's table share a great sense of responsibility
00:28to try to challenge the status quo of the diagnostic-therapeutic path of people with metastatic breast cancer in Italy,
00:38and therefore where each of us can really contribute to change things.
00:44I must say, the other very nice thing is to see not only two patient associations
00:51that work with women affected by metastatic breast cancer together,
00:57but also two pharmaceutical companies such as AstraZeneca and ICSAN,
01:01which were key in setting up this alliance,
01:06an alliance that is based on the co-development and co-commercialization of this revolution in metastatic breast cancer,
01:14and therefore, once again, to go beyond what was perhaps a world where pharmaceutical companies lived a sense of competition with each other,
01:23but to try to understand the excellences that each of them can bring to the table
01:29to try to accelerate innovation, but above all to accelerate access to these truly revolutionary drugs.
Comments